Furthermore, it was recently shown that chronic antidepressant treatments significantly activate ERK-MAPK and CaM kinase IV cascades and at the same time induce CREB phosphorylation, while

chronic selleckchem lithium downregulat.es CREB phosphorylation as well as CaM. kinase IV expression and activation in hippocampus.31,32 Figure 2 Major signaling cascades involved in the activation of the transcription factor CREB and in the long-term action of antidepressants. A number of genes Inhibitors,research,lifescience,medical are depicted, whose transcription is regulated by CREB. Trk B, tyrosine kinase B; MARK, mitogen-activated … By contrast, activation of CREB in the nucleus accumbens and other regions by substances of abuse or stress Inhibitors,research,lifescience,medical mediates some aspects of drug addiction and depressive/anxiety behaviors.23 Other transcription factors of primary importance, although less characterized compared with CREB in the mechanism of antidepressants,

arc the Fos family and NF-kB.26 It has been suggested that, activation of multiple signaling cascades impinging on CREB is required for induction of persistent changes in gene expression.33,34 This mechanism could be a way of signaling stimuli of greater significance, deserving to leave a more persistent trace in gene expression and cellular function. We have recently asked Inhibitors,research,lifescience,medical whether this notion may apply to the action Inhibitors,research,lifescience,medical of antidepressants, by analyzing the time course of activation of

multiple signaling cascades and of CREB phosphorylation after antidepressant treatments. Indeed, in our experience CREB activation and expression of a CREB -regulated gene (brain-derived neurotrophic factor, BDNF) seemed to be stronger when multiple signaling cascades were activated early and at. the same time during treatments (Musazzi et al, unpublished material). There are more than 100 identified Inhibitors,research,lifescience,medical genes regulated by CREB. Among them are such diverse genes as tyrosine hydroxylase (the rate-limiting enzyme in cathecolamine biosynthesis), the GluRl subunit of AMPA receptor for glutamate, the presynaptic protein synapsin I, the neuropeptide corticotropin releasing factor (CRF), BDNF, and many others (Figure 2). Modifications of gene expression: nearly the role of BDNF BDNF, along with its receptor TrkB, has been widely studied as a gene involved in the regulation of neuroplasticity and cognition, as well as susceptibility to various neuropsychiatrie disorders, including Alzheimer’s disease, schizophrenia, bipolar disorder, and attention deficithyperactivity disorder. Among the CREB -regulated genes, BDNF is by far the one most thoroughly studied with regard to the mechanism of antidepressants and has lately become, together with CREB activation, a sort, of readout system in the study of antidepressant mechanisms.